Characterization of Engineered Cell Lines
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : University of Miami
Other organizations : McGill University, Montreal Neurological Institute and Hospital, Mount Sinai Hospital, Lunenfeld-Tanenbaum Research Institute, University of Toronto
Variable analysis
- Knockout of MTG1, GTPBP10, or DDX28 genes in HEK293T cells
- Not explicitly mentioned
- Cell culture conditions: 37°C, 5% CO2, high-glucose, sodium pyruvate, L-glutamine DMEM medium supplemented with 10% FBS and 100 μg/ml uridine
- Mycoplasma contamination analysis routinely performed
- Positive control: HEK293T, 143B osteosarcoma, and HEK293 Flp-In T-REx 293 cell lines
- Negative control: 143B.TK- rho0 derivative (143B206) cell line
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!